Senvelgo for Cats with Diabetes - 30ml
Senvelgo for Cats: The New Treatment for Feline Diabetes
Senvelgo for Cats is an oral solution designed to manage diabetes mellitus in cats. Formulated with velagliflozin, Senvelgo offers a targeted solution for maintaining glycaemic control, providing cat owners a streamlined and effective approach to caring for feline diabetes. This product is specifically indicated for cats who are newly diagnosed with diabetes mellitus and have not been previously treated with insulin.
Senvelgo’s daily oral administration is convenient for pet owners, available either by direct oral application or through a small amount of wet food. With careful weight-based dosing, Senvelgo allows precise control over the medication quantity administered. Additionally, it does not require refrigeration, making it a practical choice for pet care.
How Senvelgo Works
Senvelgo works by reducing high blood glucose levels, or hyperglycaemia, in cats with diabetes mellitus. The active ingredient, velagliflozin, is classified as a sodium-glucose co-transporter 2 (SGLT2) inhibitor. It targets the kidney's function of glucose reabsorption, promoting the excretion of excess glucose through urine. By facilitating this process, Senvelgo helps to regulate blood glucose levels without relying on insulin injections, making it an alternative to insulin for cats not previously treated with insulin.
The action of Senvelgo is typically well-tolerated, leading to visible improvements in glycaemic control in some cats as early as the first week of treatment. This control minimises the risk of common symptoms associated with untreated or poorly managed diabetes in cats, such as excessive thirst, frequent urination, and weight loss. Moreover, the solution has a low risk of causing hypoglycaemia, a condition of dangerously low blood sugar levels, which is a concern with some diabetic treatments.
